BioScience Health Innovations BHIC
OTC BHIC
$4.01 -0.99 (-19.80%)
At close: Aug 20, 2026 · 4:00 PM EDT

BioScience Health Innovations (BHIC) Receivables - Other (2024 - 2025)

BioScience Health Innovations (BHIC) posted quarterly Receivables - Other of $137718.0 for Q4 2025, up 531.79% year-over-year from $21798.0 in Q4 2024, and up 531.79% quarter-over-quarter from $21798.0 in Q4 2024.

BioScience Health Innovations (BHIC) Receivables - Other (2024 - 2025) Analysis & Trends

BioScience Health Innovations (BHIC) has reported Receivables - Other for 2 consecutive years, with $137718.0 the latest figure, recorded in Q4 2025.

  • In Q4 2025, Receivables - Other rose 531.79% year-over-year to $137718.0; the TTM figure through Dec 2025 stood at $137718.0 (up 531.79% YoY), while the FY2025 annual figure was $137718.0, up 531.79% from the prior year.
  • Receivables - Other climbed to $137718.0 in Q4 2025 per BHIC's latest filing, from $21798.0 in the prior quarter.
  • Across five years, Receivables - Other topped out at $137718.0 in Q4 2025 and bottomed at $21798.0 in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 High Tide 215.72 Mn 182.44 Mn 35.30 Mn
2 BioScience Health Innovations 58.76 Mn 58.05 Mn 659,483.00
3 Petmed Express 38.29 Mn 25.19 Mn 11.33 Mn
4 Scienture Holdings 17.71 Mn 17.71 Mn 335,779.00
5 Polomar Health Services 8.48 Mn 8.31 Mn 935,916.00
6 Ridgetech 58,214.34 -17.85 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 137,718.00
Dec 31, 2025 137,718.00
Dec 31, 2024 21,798.00
Dec 31, 2024 21,798.00